Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Intellia Therapeutics (NTLA) has provided an update.
Intellia Therapeutics has appointed Michael P. Dube as the new principal accounting officer. With a solid background in finance and accounting, Dube brings experience from his previous role as Global Corporate Controller at Abiomed, Inc. and a decade at Deloitte & Touche LLP. His expertise as a certified public accountant reinforces Intellia’s financial leadership team as they continue to innovate in the biotechnology sector.
For a thorough assessment of NTLA stock, go to TipRanks’ Stock Analysis page.
